CA13321L1085 - Common Stock

We assign a fundamental rating of **4** out of 10 to **CCJ**. **CCJ** was compared to 210 industry peers in the **Oil, Gas & Consumable Fuels** industry. **CCJ** scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, **CCJ** is valued expensive at the moment.

The reported net income has been mixed in the past 5 years: **CCJ** reported negative net income in multiple years.

Each year in the past 5 years **CCJ** had a positive operating cash flow.

Looking at the **Return On Assets**, with a value of **2.47%**, **CCJ** is doing worse than **69.05%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 2.47% | ||

ROE | 3.84% | ||

ROIC | 2.78% |

ROA(3y)1.1%

ROA(5y)0.72%

ROE(3y)1.78%

ROE(5y)1.15%

ROIC(3y)N/A

ROIC(5y)N/A

In the last couple of years the **Profit Margin** of **CCJ** has grown nicely.

The **Operating Margin** of **CCJ** (**12.53%**) is worse than **62.38%** of its industry peers.

In the last couple of years the **Gross Margin** of **CCJ** has grown nicely.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 12.53% | ||

PM (TTM) | 9.27% | ||

GM | 22.94% |

OM growth 3YN/A

OM growth 5Y26.02%

PM growth 3YN/A

PM growth 5Y11.89%

GM growth 3Y54.28%

GM growth 5Y8.95%

Compared to 1 year ago, **CCJ** has more shares outstanding

The debt/assets ratio for **CCJ** is higher compared to a year ago.

An Altman-Z score of **5.91** indicates that **CCJ** is not in any danger for bankruptcy at the moment.

Looking at the **Altman-Z score**, with a value of **5.91**, **CCJ** belongs to the top of the industry, outperforming **89.52%** of the companies in the same industry.

The Debt to FCF ratio of **CCJ** is **4.15**, which is a neutral value as it means it would take **CCJ**, **4.15** years of fcf income to pay off all of its debts.

With a decent **Debt to Equity ratio** value of **0.17**, **CCJ** is doing good in the industry, outperforming **73.81%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.17 | ||

Debt/FCF | 4.15 | ||

Altman-Z | 5.91 |

ROIC/WACC0.36

WACC7.75%

Looking at the **Quick ratio**, with a value of **0.69**, **CCJ** is doing worse than **71.90%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 1.42 | ||

Quick Ratio | 0.69 |

Measured over the past 5 years, **CCJ** shows a small growth in **Earnings Per Share**. The EPS has been growing by **7.91%** on average per year.

Measured over the past years, **CCJ** shows a small growth in **Revenue**. The Revenue has been growing by **4.35%** on average per year.

EPS 1Y (TTM)14.04%

EPS 3YN/A

EPS 5Y7.91%

EPS Q2Q%-51.85%

Revenue 1Y (TTM)17.5%

Revenue growth 3Y12.86%

Revenue growth 5Y4.35%

Sales Q2Q%-7.71%

Based on estimates for the next years, **CCJ** will show a very strong growth in **Earnings Per Share**. The EPS will grow by **28.74%** on average per year.

The **Revenue** is expected to grow by **5.44%** on average over the next years.

EPS Next Y20.66%

EPS Next 2Y51.66%

EPS Next 3Y44.21%

EPS Next 5Y28.74%

Revenue Next Year20.49%

Revenue Next 2Y11.52%

Revenue Next 3Y9.73%

Revenue Next 5Y5.44%

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

Based on the **Price/Earnings** ratio of **101.19**, the valuation of **CCJ** can be described as expensive.

Based on the **Price/Earnings** ratio, **CCJ** is valued a bit more expensive than 77.14% of the companies in the same industry.

Based on the **Price/Forward Earnings** ratio, **CCJ** is valued a bit more expensive than 73.33% of the companies in the same industry.

When comparing the **Price/Forward Earnings** ratio of **CCJ** to the average of the S&P500 Index (**20.74**), we can say **CCJ** is valued expensively.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 101.19 | ||

Fwd PE | 35.99 |

Based on the **Enterprise Value to EBITDA** ratio, **CCJ** is valued a bit more expensive than 78.57% of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 77.04 | ||

EV/EBITDA | 58.86 |

The high **PEG Ratio(NY)**, which compensates the Price/Earnings for growth, indicates **CCJ** does not grow enough to justify the current Price/Earnings ratio.

A more expensive valuation may be justified as **CCJ**'s earnings are expected to grow with **44.21%** in the coming years.

PEG (NY)4.9

PEG (5Y)12.8

EPS Next 2Y51.66%

EPS Next 3Y44.21%

With a yearly dividend of 0.19%, **CCJ** is not a good candidate for dividend investing.

With a **Dividend Yield** of **0.19**, **CCJ** pays less dividend than the S&P500 average, which is at **2.29**.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 0.19% |

The dividend of **CCJ** decreases each year by **-7.75%**.

As **CCJ** did not decrease their dividend in the past **5** years, we can say the dividend looks stable.

Dividend Growth(5Y)-7.75%

Div Incr Years0

Div Non Decr Years5

DP22.18%

EPS Next 2Y51.66%

EPS Next 3Y44.21%

**CAMECO CORP**

NYSE:CCJ (7/23/2024, 1:50:48 PM)

**47.56**

**-0.05 (-0.11%) **

Chartmill FA Rating

GICS SectorEnergy

GICS IndustryGroupEnergy

GICS IndustryOil, Gas & Consumable Fuels

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap20.70B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 0.19% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 101.19 | ||

Fwd PE | 35.99 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)4.9

PEG (5Y)12.8

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 2.47% | ||

ROE | 3.84% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 12.53% | ||

PM (TTM) | 9.27% | ||

GM | 22.94% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.27

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.17 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 1.42 | ||

Quick Ratio | 0.69 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)14.04%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y20.66%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)17.5%

Revenue growth 3Y12.86%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y